VicorderCS NIBP Validation Study to Review The Ability to Capture Blood Pressure Measurements

Part of paid clinical trials in Breckenridge, Colorado.

Sponsor
80 Beats Medical
Study ID
NCT06560034
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • VicorderCS — DEVICE
    1. Vascular Sensor (VCS-VAS-1000) measurement device used with accessories (cuffs and tubes) connected to the device; 2. Data Station (VCS-DAT-1000) for data collection and analysis

Study Details

80 Beats Medical introduces the VicorderCS, the next generation of our Vicorder technology designed to manage hypertension and cardiovascular risks. This advanced diagnostic equipment offers non-invasive collection and computation of a plethora of cardiovascular markers. It is faster, easier to use, and more portable than its predecessor, with enhanced connectivity options for extended marker collection and analysis. These markers enable early diagnosis of cardiovascular disease, ensuring positive patient outcomes. With a strong foundation in numerous published clinical studies, the VicorderCS enhances data collection and analysis capabilities, empowering the research community in developing new drugs and therapeutics. This validation study is purposed to evaluate one of the physiological parameters that is measured by the VicorderCS system, which is Non-invasive Blood Pressure (NIBP) via the common oscillometric cuff-based method.

Key Dates

Start date
Aug 15, 2024
Status verified
Aug 2024
Primary completion
Aug 1, 2025
Completion
Aug 1, 2025

Study Design

Enrollment
120 participants (estimated)

Arms

  • Arm: Cross-Sectional Group
    Blood pressure reading of one group of participants

Primary Outcome Measure

Blood Pressure Reading [ Time Frame: One visit (1hour) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Manos Health Study SiteBreckenridgeColorado80424
Brian Van Winkle, MBA
202-539-6941
Nitin Vaswani, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Breckenridge, CO

Related Studies